European Commission approves Kimberly-Clark's $40 billion acquisition of Kenvue

The European Commission approved Kimberly-Clark's $40 billion acquisition of Tylenol maker Kenvue on October 13, 2026, following commitments to address antitrust concerns. To clear regulatory hurdles, Kimberly-Clark agreed to divest its European feminine hygiene brands—including Kotex, Camelia, and Record—to Turkey-based distributor Dilek Gida Uretim. Regulators found the remedy fully resolved competition issues in tampon markets across the Czech Republic, Estonia, and Slovakia.

Kimberly-Clark acquisition of Kenvue

• ▪The acquisition of Kenvue by Kimberly-Clark combines the manufacturer of Kleenex tissues and Huggies diapers with the maker of Tylenol to form a global health conglomerate.
• ▪The European Commission approved Kimberly-Clark's $40 billion acquisition of Kenvue on October 13, 2026, subject to specified remedy conditions.

EU antitrust concerns

• ▪The European Commission initially raised concerns that Kimberly-Clark's acquisition of Kenvue would reduce competition in European tampon markets.
• ▪Conditional approval by the European Commission cleared a major regulatory obstacle for Kimberly-Clark's $40 billion takeover of Kenvue.

Feminine hygiene brand divestment

• ▪The feminine hygiene assets divested by Kimberly-Clark in Europe include the Kotex, Lidie, Camelia, and Record brands.
• ▪To satisfy European antitrust requirements, Kimberly-Clark offered to divest all of its tampon and feminine hygiene brands within the European Economic Area.

Dilek Gida asset purchase

• ▪Turkey-based consumer goods distributor Dilek Gida Uretim agreed to purchase the European feminine hygiene assets divested by Kimberly-Clark.
• ▪The European Commission approved Dilek Gida Uretim as a buyer, determining it possesses the financial resources and expertise to operate the divested business effectively.

Tampon market competition issues

• ▪European regulators found that Kimberly-Clark's acquisition of Kenvue specifically threatened tampon market competition in the Czech Republic, Estonia, and Slovakia.
• ▪The European Commission concluded that the acquisition of Kenvue by Kimberly-Clark would unacceptably remove an important supplier from regional tampon markets.

Debatable claims

• ▪Divesting European feminine hygiene brands sufficiently protects competition in the Kimberly-Clark Kenvue merger
• ▪Antitrust authorities should ban consolidation among major global personal care product manufacturers